Amitzur G, Pogatz V, Novikov I, Kaplinsky E, Eldar M
Neufeld Cardiac Research Institute, Sackler School of Medicine, Tel Aviv University, Sheba Medical Center, Tel Hashomer, Israel.
J Cardiovasc Pharmacol. 2000 Jan;35(1):16-28. doi: 10.1097/00005344-200001000-00003.
The individual activities of sodium versus calcium channels in the initiation and maintenance of ventricular fibrillation (VF) have not been fully elucidated. Therefore we studied in isolated heart under nonischemic conditions (a) VF characteristics in untreated hearts, (b) initiation and maintenance of VF during attenuation and blockade of slow calcium channel activity by verapamil, (c) the effect of these interventions on the characteristics of the induced arrhythmia, and (d) the impact of heart weight on the observed results. Measurements were carried out in both ventricles of isolated feline hearts during ventricular pacing and 8 min of electrically induced tachyarrhythmias. Measurements during ventricular pacing included epicardial conduction time (CON), refractoriness (VRP), and all tissue resistivity (ATR; an indirect measure of changes in intercellular electrical coupling). Measurements during arrhythmia included ATR, peak frequency [PKF; a measure of the prevailing frequency based on Fast Fourier Transform (FFT) analysis], and normalized entropy (ENTROP; a measure of the degree of arrhythmia organization). Measurements during sinus rhythm and arrhythmia were repeated after blocking of calcium channel activity by verapamil at a high concentration (1.8x10(-4) M; n = 8) and at two low concentrations (1.5 and 3.0x10(-7) M; n = 8). In untreated hearts, mainly VF episodes were induced, exhibiting a low degree of organization with no significant change in this parameter throughout the arrhythmia (8 min). In the left ventricle (LV; and to a much smaller extent in the right ventricle; RV), a gradual increase in PKF was observed throughout the arrhythmia, with no significant change in ATR. Verapamil at a high concentration increased CON, but did not affect VRP. These findings were similar in both ventricles. In lower verapamil concentrations, CON was not affected, and VRP was slightly shortened. After treatment with a high verapamil concentration, VF could not be induced in small hearts but was always inducible in large hearts. Transient arrhythmia episodes appeared in 9% of untreated hearts, in 25% with "high" verapamil, and in 25-37% with "low" verapamil. With all verapamil concentrations, the induced arrhythmia was modulated from a predominantly VF to PVT or MVT type, manifested by a decrease in ENTROP. This effect was less pronounced with increasing heart weight. No significant change in PKF and in ATR was obtained with verapamil throughout the arrhythmia. It is suggested that verapamil modulation of arrhythmia organization is associated mainly with a direct blockade of calcium channel activity (perhaps by causing reduction in the safety factor for conduction), rather than with indirect modulation of electrophysiological parameters.
钠通道与钙通道在心室颤动(VF)的起始和维持过程中的个体活动尚未完全阐明。因此,我们在非缺血条件下的离体心脏中进行了研究:(a)未处理心脏的VF特征;(b)通过维拉帕米衰减和阻断慢钙通道活性期间VF的起始和维持;(c)这些干预措施对诱发心律失常特征的影响;(d)心脏重量对观察结果的影响。在心室起搏和8分钟电诱发快速心律失常期间,对离体猫心脏的两个心室进行测量。心室起搏期间的测量包括心外膜传导时间(CON)、不应期(VRP)和所有组织电阻率(ATR;细胞间电耦合变化的间接测量指标)。心律失常期间的测量包括ATR、峰值频率[PKF;基于快速傅里叶变换(FFT)分析的主导频率测量指标]和归一化熵(ENTROP;心律失常组织程度的测量指标)。在高浓度(1.8×10⁻⁴ M;n = 8)和两个低浓度(1.5和3.0×10⁻⁷ M;n = 8)的维拉帕米阻断钙通道活性后,重复窦性心律和心律失常期间的测量。在未处理的心脏中,主要诱发VF发作,其组织程度较低,在整个心律失常过程(8分钟)中该参数无显著变化。在左心室(LV;右心室变化较小;RV)中,在整个心律失常过程中观察到PKF逐渐增加,而ATR无显著变化。高浓度的维拉帕米增加了CON,但不影响VRP。两个心室的这些发现相似。在较低的维拉帕米浓度下,CON不受影响,VRP略有缩短。用高浓度维拉帕米处理后,小心脏中不能诱发VF,但大心脏中总是可诱发VF。在9%的未处理心脏、25%使用“高”浓度维拉帕米的心脏以及25 - 37%使用“低”浓度维拉帕米的心脏中出现短暂性心律失常发作。使用所有维拉帕米浓度时,诱发的心律失常从主要的VF型转变为室性早搏(PVT)或室性心动过速(MVT)型,表现为ENTROP降低。随着心脏重量增加,这种效应不太明显。在整个心律失常过程中,维拉帕米对PKF和ATR没有显著影响。提示维拉帕米对心律失常组织的调节主要与钙通道活性的直接阻断有关(可能是通过降低传导安全因子),而不是与电生理参数的间接调节有关。